Skip to main content

Table 2 Univariate and multivariate analysis of prognostic parameters of clinical LUAD patients using Cox regression

From: PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma

Characteristics Univariate analysis Multivariate analysis
HR P value 95%CI HR P value 95%CI
Expression of PAFAH1B3
(low vs.high)
2.240 0.019* 1.141–4.394 1.991 0.046* 1.011–3.921
Age (years)
(<60 vs. ≥ 60)
1.394 0.248 0.793–2.450    
Gender
(male vs.female)
1.320 0.335 0.751–2.320    
Primary tumor
(T1 vs.T2 vs.T3 + T4)
1.104 0.632 0.736–1.658    
Lymph node metastasis
(No vs.Yes)
3.389 0.000*** 1.824–6.297    
Distant metastasis
(No vs.Yes)
6.014 0.000*** 3.086–11.72    
TNM stage
(I + II vs.III + IV)
1.937 0.000*** 1.431–2.621 1.884 0.000*** 1.390–2.552
  1. TNM stage contains lymph node metastasis and distant metastasis, therefore, lymph node metastasis and distant metastasis was not included in the multivariate analysis
  2. CI Confidence interval, HR Hazard ratio. *P < 0.05, **P < 0.01, ***P < 0.001